ECO Animal Health Group (LON:EAH) Shares Pass Below 200 Day Moving Average – Here’s What Happened

Shares of ECO Animal Health Group plc (LON:EAH) passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 98.91 ($1.25) and traded as low as GBX 68.08 ($0.86). ECO Animal Health Group shares last traded at GBX 69 ($0.87), with a volume of 184,678 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Shore Capital reiterated a “buy” rating on shares of ECO Animal Health Group in a report on Friday, November 29th.

ECO Animal Health Group Stock Performance

The company has a debt-to-equity ratio of 4.31, a current ratio of 2.96 and a quick ratio of 2.14. The stock has a fifty day simple moving average of GBX 69.91 and a two-hundred day simple moving average of GBX 98.78. The firm has a market capitalization of £46.74 million, a P/E ratio of 3,450.00 and a beta of -0.05.

Insider Activity

In other news, insider David Hallas bought 15,500 shares of the business’s stock in a transaction that occurred on Monday, December 2nd. The shares were bought at an average cost of GBX 74 ($0.93) per share, for a total transaction of £11,470 ($14,476.84). 21.65% of the stock is currently owned by company insiders.

About ECO Animal Health Group

ECO Animal Health Group plc, together with its subsidiaries, develops, registers, and markets pharmaceutical products for animals worldwide. The company provides Aivlosin, a macrolide antibiotic for the treatment of enteric and respiratory diseases in pigs and poultry. It also offers generic drugs, such as Ecomectin, Ecoheart, Ecotraz, and Ecomintic, which are endectocides and other antiparasitics for the treatment and prevention of parasites, such as worms, ticks, mange, and lices in cattle, sheep, pigs, horses, and dogs; and Chlortetracycline and Oxytetracycline for treatment of bacterial infections in pigs, poultry, and cattle.